Navigation Links
Patient's whole genome reveals risk of diseases and adverse drug responses
Date:4/29/2010

Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.

The analysis, which was supported by the National Institutes of Health (NIH), appears in the May 1, 2010 issue of Lancet.

The authors evaluated the entire genome of a 40-year old man and compared it to several databases of disease-related gene variants. They also factored in the patient's medical and family history and statistical disease risks. As part of the work, the researchers provided the patient with genetic counseling and clinical tests relevant to his family history.

The genome analysis revealed variants associated with diseases in the man's family (osteoarthritis, vascular disease and early sudden death). It also uncovered variants linked to conditions not in his family (iron overload and thyroid and parathyroid diseases). Some variants suggested that he might have unusual responses to certain heart medications, which is meaningful in light of his risk for cardiovascular disorders.

The authors view their work as a proof of concept that whole-genome sequencing can yield clinically useful information for individual patients. They acknowledge that many challenges remain, including the effect of the environment, which is difficult to quantify and often changes throughout a person's life. The paper concludes that the transition to genome-informed medical care will require an integrated team including medical and genetics professionals, ethicists and health-care delivery organizations.


'/>"/>

Contact: Alisa Machalek
alisa.machalek@nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Best care for the oldest lung cancer patients
2. NIH study offers hope to patients with nonalcoholic steatohepatitis
3. Causes of death in AIDS patients
4. Pediatric Patients and Siblings Enjoy Beverly Hills Beauty Makeover
5. Experimental Drug Offers Hope for Cystic Fibrosis Patients
6. Use and costs of diagnostic imaging increasing for patients with cancer
7. Imaging Costs Soar for Medicare Cancer Patients
8. Better vision ahead for many diabetic retinopathy patients
9. Alcoholic cirrhosis patients had high prevalence of complications at diagnosis
10. New reliable method based on patients gait helps to diagnose fibromyalgia
11. Patients, clinicians favor disclosure of financial ties to industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... of the antioxidant urate to protect against the ... on more than urate,s ability to protect against ... the open-access journal PLoS One , researchers ... describe experiments suggesting the involvement of a novel ... against Parkinson,s-like damage. , "Our experiments showed, ...
(Date:5/23/2012)... A new study at Karlstad University in Sweden shows ... by our bodies. Phthalates are substances suspected to cause ... in children. The study shows that children can ingest ... and through the skin. , Phthalates are a group ... a great number of common consumer goods such as ...
(Date:5/23/2012)... ATS 2012, SAN FRANCISCO The number of viral ... in childhood, according to a new study from researchers ... infancy predicted wheezing later in childhood, this association was ... , "Viral infections in infancy, particularly rhinovirus, are thought ... but it is unclear whether this association is due ...
(Date:5/22/2012)... imaging (MRI) provides an indication of a breast ... possible through clinical examination, according to a new ... . , Women with breast cancer often ... that women who receive this treatment, known as ... conservation than those receiving chemotherapy after surgery. , ...
(Date:5/22/2012)... The University of Kentucky Markey Cancer Center has received ... and bone marrow disease often caused by chemotherapy or ... P. Evans Foundation, along with a $1.25 million donor ... The Evans Foundation grant will fund five research labs ... at Cincinnati Children,s Hospital, and one at the University ...
Breaking Medicine News(10 mins):Health News:Study supports urate protection against Parkinson's disease, hints at novel mechanism 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3
... The in-depth report examining internet pharmacies and life-saving ... EAASM at the 4th Global Forum ... Washington DC., WASHINGTON, June 5 The ... today unveiled its comprehensive research report,-- The Counterfeiting ...
... as Study Lends Scientific ... Arthritis Pain, SPARTA, Mich., June 5 Consumers who ... yet hesitate,to pay the premium price functional juices often command, ... Brand,s 100%,Pure Tart Cherry juice product has been added to ...
... for the World,s Longest Indoor Stair Climb Benefiting,the Damon ... Registration for Go Vertical,Chicago 2008, the annual charitable stair ... 9 a.m. CDT Tuesday, June 10 at http://www.goverticalchicago.org ... place on the morning of,November 9th, 2008, is limited ...
... Cornerstone Events of National Health IT Week, June ... through IT, WASHINGTON, June 5 The ... Information and Management,Systems Society:, (Logo: http://www.newscom.com/cgi-bin/prnh/20060801/CGTU009LOGO-a ... http://www.himsssummit.org/ ) will be held June 9-10,2008. ...
... Institution,s Department of Embryology, has been awarded the 2008 ... in recognition of his contributions to fruit fly genomics ... reproduction." The prize, which consists of a gold ... the International Congress of Genetics in Berlin on July ...
... Society, AKRON, Ohio, June 5 In an ... LLC (VHT) is proud to participate in,the American Cancer ... at Copley High School., (Logo: http://www.newscom.com/cgi-bin/prnh/20070619/CLTU033LOGO ... are expected to diagnose,more than 1.3 million new cancer ...
Other Medicine News:Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 3Health News:Reported Health Benefits of Tart Cherry Boosts Juice Distribution in Southern U.S. 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 3Health News:HIMSS Summit08 and Advocacy Day 2Health News:2008 Gruber Genetics Prize awarded to Allan Spradling of Carnegie Institution 2Health News:Virtual Hold Technology to Support Relay for Life of Westside 2
(Date:5/23/2012)... 2012  Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical ... for its U.S. phase 2 clinical trial, T ... G reater E fficacy T rial ... in patients with non-tuberculous mycobacterial (NTM) lung disease. ... to support current NTM treatment recommendations, and no new ...
(Date:5/23/2012)... Calif., May 23 2012  Isis Pharmaceuticals, Inc. ... webcast:What:Data from KYNAMRO™ presented at EAS 2012When:Friday, June ... PTWhere:www.isispharm.comHow:Live on the Internet.  Simply log onto our ... to participate during the live event, a replay ... limited time at www.isispharm.com . ...
(Date:5/23/2012)... 2012 Reportlinker.com announces that a new ... The Medical Device Market: ... Summary Espicom,s in-depth medical ... to understand the key drivers in medical markets ... data. Each report opens with an outlook section ...
Breaking Medicine Technology:Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5The Medical Device Market: USA 2The Medical Device Market: USA 3The Medical Device Market: USA 4The Medical Device Market: USA 5The Medical Device Market: USA 6The Medical Device Market: USA 7The Medical Device Market: USA 8Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 1Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 2Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 3Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 1Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 2Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 3Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 4Internet Can Help Curb Drinking Among College Students 57382 1Internet Can Help Curb Drinking Among College Students 57382 2
... Efficacy Results Support Follow-on NEST-3 TrialCARLSBAD, Calif., Feb. ... PhotoThera, Inc., transcranial laser therapy (TLT) for acute ... demonstrated improved outcomes for patients, but did not ... analysis in patients who had moderate to moderately ...
... Bulletin Board: GOVX), an Atlanta-based, publicly traded,biopharmaceutical company ... Immunodeficiency Virus) and other infectious agents, announced,the first ... Trial for its,candidate HIV/AIDS vaccine. The trial, ... Vaccine Trials Network (HVTN). The HVTN, funded ...
Other Medicine Technology:Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009 2GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 2GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 3GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 4GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 5
... onlays are pre-cut and pre-shaped to facilitate ... more frequently done. These pre-shaped onlays are ... Ultra and are designed for use in ... both small and large sizes, they provide ...
... and soft tissue reconstructions, and in ... is sometimes necessary to encourage host ... minimizing tissue attachment along another surface.,GORE ... ePTFE sheet material that offers a ...
... is pleased to announce the latest advancement ... E/X mesh.,When Bard Composix mesh was introduced ... hernia repair prosthesis that combined two clinically ... in one product. Bard Composix E/X mesh, ...
... introduction in 1958, Bard mesh has become ... are compared. Bard mesh was used by ... the "tension-free" hernia repair many years ago. ... and ideal" substance for permanent reinforcement of ...
Medicine Products: